A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma

Published:2017-07 Issue: Volume:70 Page:7-13
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Ke Liang-Ru,Xia Wei-Xiong,Qiu Wen-Ze,Huang Xin-Jun,Yu Ya-Hui,Liang Hu,Liu Guo-Ying,Xiang Yan-Qun,Guo Xiang,Lv Xing

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference33 articles.

1. Is nasopharyngeal cancer really a “Cantonese cancer”?;Wee;Chin J Cancer,2010

2. The prevalence and prevention of nasopharyngeal carcinoma in China;Cao;Chin J Cancer,2011

3. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience;Lee;Int J Radiat Oncol Biol Phys,2002

4. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure;Lee;Int J Radiat Oncol Biol Phys,1992

5. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma;Oral Oncology;2024-11

2. Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study;Translational Oncology;2024-10

3. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07

4. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02

5. MRI-based clinical radiomics nomogram may predict the early response after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma;Frontiers in Oncology;2023-05-15